• The company will attend the 2019 RCOG World Conference in London & 
ESHRE Annual Meeting in Vienna

• Guerbet also highlights the value of Hysterosalpingography (HSG) in Infertility 
Management

Villepinte (France), June 12, 2019 - Guerbet (FR0000032526 GBT), a global specialist of contrast agents and solutions for medical imaging, reaffirms its commitment to Women’s Health with its participation to two upcoming conferences: the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress 2019, which will take place in London, from June 17 to 19, and the European Society of Human Reproduction & Embryology (ESHRE) 2019 Annual Meeting, which will be held in Vienna, from June 23 to 26. The company also highlights the value of HSG within Infertility Management.

Infertility is defined as the inability to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. It is estimated that one in six couples faces infertility1. Main causes of women infertility include Fallopian tubes abnormalities, ovulation disorders, endometriosis & unexplained infertility.

Sub-fertile couples undergo a series of fertility tests. Fallopian tubes and uterine cavity assessment is an important step within infertility workup, performed mainly by HSG procedure. HSG is endorsed by main international clinical practice guidelines (NICE: The National Institute for Health and Care Excellence, ASRM: American Society for Reproductive Medicine, FIGO: International Federation of Gynecology and Obstetrics, CFAS: Canadian Fertility & Andrology Society) as part of the overall fertility assessment 2,3,4,5. This procedure requires the injection of a contrast agent into the uterine cavity & tubes under fluoroscopy monitoring.

Beyond its diagnostic efficacy, HSG also proves pregnancy improvement for couples with unexplained subfertility compared to no HSG 6,7,8,9. The mechanism-of-action remains unclear, tubal flushing might dislodge non-occlusive debris from Fallopian tubes, also it has been suggested a possible immunobiological effect by inducing some peritoneal & endometrial immunobiological modulations helping for better endometrial bathing 6,10,11,12.

“Hysterosalpingography is the standard of care for evaluating tubal patency within Infertility Management, and we rely on the only oil-based contrast medium Lipiodol^® Ultra Fluid, Guerbet’s flagship contrast agent, for tubal flushing for infertile women” explained Thomas Bonnefont, VP Commercial Interventional Imaging for Guerbet.

HSG procedure